1
|
Gonçalves MN, Lopes DS, Teixeira SC, Teixeira TL, de Freitas V, Costa TR, Gimenes SNC, de Camargo IM, de Souza G, da Silva MS, Azevedo FVPDV, Grego KF, Santos LC, Oliveira VQ, da Silva CV, Rodrigues RS, Yoneyama KAG, Clissa PB, Rodrigues VDM. Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2023; 118:e220225. [PMID: 38018570 PMCID: PMC10690931 DOI: 10.1590/0074-02760220225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 11/01/2023] [Indexed: 11/30/2023] Open
Abstract
BACKGROUND Leishmaniasis, a neglected disease caused by the parasite Leishmania, is treated with drugs associated with high toxicity and limited efficacy, in addition to constant reports of the emergence of resistant parasites. In this context, snake serums emerge as good candidates since they are natural sources with the potential to yield novel drugs. OBJECTIVES We aimed to show the antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, against Leishmania (Leishmania) amazonensis. METHODS Promastigotes forms were exposed to γCdcPLI, and we assessed the parasite viability and cell cycle, as well as invasion and proliferation assays. FINDINGS Despite the low cytotoxicity effect on macrophages, our data indicate that γCdcPLI has a direct effect on parasites promoting an arrest in the G1 phase and reduction in the G2/M phase at the highest dose tested. Moreover, this PLA2 inhibitor reduced the parasite infectivity when promastigotes were pre-treated. Also, we demonstrated that the γCdcPLI treatment modulated the host cell environment impairing early and late steps of the parasitism. MAIN CONCLUSIONS γCdcPLI is an interesting tool for the discovery of new essential targets on the parasite, as well as an alternative compound to improve the effectiveness of the leishmaniasis treatment.
Collapse
Affiliation(s)
- Marina Neves Gonçalves
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| | - Daiana Silva Lopes
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
- Universidade Federal da Bahia, Instituto de Biociências, Vitória da
Conquista, BA, Brasil
| | - Samuel Cota Teixeira
- Universidade Federal de Uberlândia, Instituto de Ciências
Biomédicas, Departamento de Imunologia, Uberlândia, MG, Brasil
| | - Thaise Lara Teixeira
- Universidade Federal de São Paulo, Escola Paulista de Medicina,
Departamento de Microbiologia, Imunologia e Parasitologia, São Paulo, SP,
Brasil
| | - Vitor de Freitas
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| | - Tássia Rafaella Costa
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| | | | | | - Guilherme de Souza
- Universidade Federal de Uberlândia, Instituto de Ciências
Biomédicas, Departamento de Imunologia, Uberlândia, MG, Brasil
| | - Marcelo Santos da Silva
- Universidade de São Paulo, Instituto de Química, Departamento de
Bioquímica, São Paulo, SP, Brasil
| | | | | | - Luísa Carregosa Santos
- Universidade Federal da Bahia, Instituto de Biociências, Vitória da
Conquista, BA, Brasil
| | | | - Claudio Vieira da Silva
- Universidade Federal de Uberlândia, Instituto de Ciências
Biomédicas, Departamento de Imunologia, Uberlândia, MG, Brasil
| | - Renata Santos Rodrigues
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| | - Kelly Aparecida Geraldo Yoneyama
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| | | | - Veridiana de Melo Rodrigues
- Universidade Federal de Uberlândia, Instituto de Biotecnologia,
Laboratório de Bioquímica e Toxinas Animais, Uberlândia, MG, Brasil
| |
Collapse
|
3
|
Aloui Z, Messaoud C, Haoues M, Neffati N, Bassoumi Jamoussi I, Essafi-Benkhadir K, Boussaid M, Guizani I, Karoui H. Asteraceae Artemisia campestris and Artemisia herba-alba Essential Oils Trigger Apoptosis and Cell Cycle Arrest in Leishmania infantum Promastigotes. Evid Based Complement Alternat Med 2016; 2016:9147096. [PMID: 27807464 PMCID: PMC5078739 DOI: 10.1155/2016/9147096] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/27/2016] [Revised: 06/06/2016] [Accepted: 08/10/2016] [Indexed: 11/17/2022]
Abstract
We report the chemical composition and anti-Leishmania and antioxidant activity of Artemisia campestris L. and Artemisia herba-alba Asso. essential oils (EOs). Our results showed that these extracts exhibit different antioxidant activities according to the used assay. The radical scavenging effects determined by DPPH assay were of IC50 = 3.3 mg/mL and IC50 = 9.1 mg/mL for Artemisia campestris and Artemisia herba-alba essential oils, respectively. However, antioxidant effects of both essential oils, determined by ferric-reducing antioxidant power (FRAP) assay, were in the same range (2.3 and 2.97 mg eq EDTA/g EO, resp.), while the Artemisia herba-alba essential oil showed highest chelating activity of Fe2+ ions (27.48 mM Fe2+). Interestingly, we showed that both EOs possess dose-dependent activity against Leishmania infantum promastigotes with IC50 values of 68 μg/mL and 44 μg/mL for A. herba-alba and A. campestris, respectively. We reported, for the first time, that antileishmanial activity of both EOs was mediated by cell apoptosis induction and cell cycle arrest at the sub-G0/G1 phase. All our results showed that EOs from A. herba-alba and A. campestris plants are promising candidates as anti-Leishmania medicinal products.
Collapse
Affiliation(s)
- Zohra Aloui
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Chokri Messaoud
- Unité Ressources Phytogénétiques et Biotechnologie Végétale, INSAT, BP 676, 1080 Tunis, Tunisia
| | - Meriam Haoues
- Laboratoire de Recherche sur la Transmission, le Contrôle et l'Immunobiologie des Infections LR11IPT02, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Noura Neffati
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Imen Bassoumi Jamoussi
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Khadija Essafi-Benkhadir
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Mohamed Boussaid
- Unité Ressources Phytogénétiques et Biotechnologie Végétale, INSAT, BP 676, 1080 Tunis, Tunisia
| | - Ikram Guizani
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| | - Habib Karoui
- Laboratoire d'Epidémiologie Moléculaire et Pathologie Expérimentale Appliquée aux Maladies Infectieuses LR11IPT04, Université de Tunis El Manar, Institut Pasteur de Tunis, 13 Place Pasteur, BP 74, 1002 Tunis, Tunisia
| |
Collapse
|